ProfileGDS4718 / 208931_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 73% 73% 77% 75% 88% 89% 76% 73% 81% 82% 69% 80% 87% 88% 81% 80% 82% 86% 73% 78% 78% 82% 81% 80% 88% 77% 84% 84% 84% 81% 89% 68% 77% 80% 81% 83% 75% 73% 74% 79% 77% 77% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.5621985
GSM549102patient 115, normal, homogenized [OPG study]7.0818173
GSM549104patient 119, normal, homogenized [OPG study]7.2181573
GSM549108patient 138, normal, homogenized [OPG study]7.470777
GSM549119patient 077, normal, homogenized [OPG study]7.2820375
GSM549133patient 032, cancer, homogenized [OPG study]9.0164288
GSM549139patient 042, cancer, homogenized [OPG study]9.0288589
GSM549099patient 107, normal, homogenized [OPG study]7.3932176
GSM549109patient 139, normal, homogenized [OPG study]7.0737873
GSM549110patient 046, normal, homogenized [OPG study]7.9721581
GSM549114patient 063, normal, homogenized [OPG study]8.2097982
GSM549122patient 082, normal, homogenized [OPG study]6.8432969
GSM549134patient 033, cancer, homogenized [OPG study]7.9040180
GSM549136patient 036, cancer, homogenized [OPG study]8.860287
GSM549140patient 044, cancer, homogenized [OPG study]9.003688
GSM549111patient 047, normal, homogenized [OPG study]8.0186781
GSM549113patient 057, normal, homogenized [OPG study]7.8912880
GSM549132patient 031, cancer, homogenized [OPG study]8.1135582
GSM549137patient 038, cancer, homogenized [OPG study]8.572986
GSM549142patient 047, cancer, homogenized [OPG study]7.0842373
GSM549100patient 110, normal, homogenized [OPG study]7.5948578
GSM549107patient 135, normal, homogenized [OPG study]7.6954378
GSM549115patient 068, normal, homogenized [OPG study]8.2245582
GSM549116patient 072, normal, homogenized [OPG study]8.0600381
GSM549120patient 078, normal, homogenized [OPG study]7.8242780
GSM549131patient 030, cancer, homogenized [OPG study]8.9687388
GSM549118patient 074, normal, homogenized [OPG study]7.5314977
GSM549129patient 027, cancer, homogenized [OPG study]8.2659684
GSM549123patient 088, normal, homogenized [OPG study]8.3912284
GSM549124patient 006, cancer, homogenized [OPG study]8.2669784
GSM549126patient 015, cancer, homogenized [OPG study]7.9624381
GSM549128patient 025, cancer, homogenized [OPG study]9.054189
GSM549103patient 117, normal, homogenized [OPG study]6.6547868
GSM549117patient 073, normal, homogenized [OPG study]7.5113177
GSM549138patient 041, cancer, homogenized [OPG study]7.855680
GSM549141patient 045, cancer, homogenized [OPG study]8.135681
GSM549130patient 028, cancer, homogenized [OPG study]8.1424383
GSM549101patient 111, normal, homogenized [OPG study]7.2858775
GSM549105patient 128, normal, homogenized [OPG study]7.0824573
GSM549106patient 134, normal, homogenized [OPG study]7.3784974
GSM549112patient 048, normal, homogenized [OPG study]7.8072779
GSM549125patient 011, cancer, homogenized [OPG study]7.444877
GSM549127patient 024, cancer, homogenized [OPG study]7.6149177
GSM549135patient 035, cancer, homogenized [OPG study]9.303490